Scepticaemia: The impact on the health system and patients of delaying new treatments with uncertain evidence; a case study of the sepsis bundle [version 1; referees: 2 approved]
Background: A sepsis care bundle of intravenous vitamin C, thiamine, and hydrocortisone was reported to improve treatment outcomes. The data to support it are uncertain and decision makers are likely to be cautious about adopting it. The objective of this study was to model the opportunity costs in...
Main Authors: | Robin Blythe, David Cook, Nicholas Graves |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2018-04-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/7-500/v1 |
Similar Items
-
Scepticaemia: The impact on the health system and patients of delaying new treatments with uncertain evidence; a case study of the sepsis bundle [version 2; referees: 2 approved]
by: Robin Blythe, et al.
Published: (2018-07-01) -
Recent advances in understanding and managing sepsis [version 1; referees: 3 approved]
by: Daniela Berg, et al.
Published: (2018-09-01) -
C3 glomerulopathy [version 1; referees: 4 approved]
by: H. Terence Cook
Published: (2017-03-01) -
Mechanisms of pathogenesis of emerging adenoviruses [version 1; referees: 2 approved]
by: James Cook, et al.
Published: (2017-01-01) -
Behavioural evidence for self-medication in bumblebees? [version 3; referees: 3 approved]
by: David Baracchi, et al.
Published: (2015-10-01)